In thisstudy, we aimed to investigate the significance of PCGEM1 in the treatment withmontelukast sodium for children with CVA, so as to develop novel therapies that canbe better targeted toward CVA-specific characteristics. This evidence concerns the gene PCGEM1 and stroke disorder.